Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C27H45O5S.Na |
| Molecular Weight | 504.698 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 8 / 8 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Na+].C[C@H](CCCC(C)(C)O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@H](CC[C@]4(C)[C@H]3CC[C@]12C)OS([O-])(=O)=O
InChI
InChIKey=OEGAOHNRCSZIRO-KSGNISEOSA-M
InChI=1S/C27H46O5S.Na/c1-18(7-6-14-25(2,3)28)22-10-11-23-21-9-8-19-17-20(32-33(29,30)31)12-15-26(19,4)24(21)13-16-27(22,23)5;/h8,18,20-24,28H,6-7,9-17H2,1-5H3,(H,29,30,31);/q;+1/p-1/t18-,20+,21+,22-,23+,24+,26+,27-;/m1./s1
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
586317
Created by
admin on Tue Apr 01 20:44:54 GMT 2025 , Edited by admin on Tue Apr 01 20:44:54 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
JK-16
Created by
admin on Tue Apr 01 20:44:54 GMT 2025 , Edited by admin on Tue Apr 01 20:44:54 GMT 2025
|
PRIMARY | |||
|
1174047-40-5
Created by
admin on Tue Apr 01 20:44:54 GMT 2025 , Edited by admin on Tue Apr 01 20:44:54 GMT 2025
|
PRIMARY | |||
|
71A5JOPBE8
Created by
admin on Tue Apr 01 20:44:54 GMT 2025 , Edited by admin on Tue Apr 01 20:44:54 GMT 2025
|
PRIMARY | |||
|
25208970
Created by
admin on Tue Apr 01 20:44:54 GMT 2025 , Edited by admin on Tue Apr 01 20:44:54 GMT 2025
|
PRIMARY | |||
|
300000031616
Created by
admin on Tue Apr 01 20:44:54 GMT 2025 , Edited by admin on Tue Apr 01 20:44:54 GMT 2025
|
PRIMARY | |||
|
C184929
Created by
admin on Tue Apr 01 20:44:54 GMT 2025 , Edited by admin on Tue Apr 01 20:44:54 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD
